STORY CONTINUES BELOW THESE SALTWIRE VIDEOS - Drugmaker Scynexis said on Monday it would voluntarily recall its antifungal drug Brexafemme from the market and put a temporary hold on studies of the therapy due to the potential risk of cross contamination with another compound.
Scynexis said it became aware that substances used to make beta-lactam, which can cause allergic reactions, are manufactured using equipment common to the manufacturing process for Brexafemme.
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오: